Graduate Thesis Or Dissertation
 

Development of mucosal vaccines for avian influenza A virus composed of recombinant Lactococcus lactis and Streptococcus gordonii

Público Deposited

Contenido Descargable

Descargar PDF
https://ir.library.oregonstate.edu/concern/graduate_thesis_or_dissertations/2514np76t

Descriptions

Attribute NameValues
Creator
Abstract
  • Novel mucosal vaccines (LL-M2e, LL-HAe, SG-HAe) were constructed from live, non-pathogenic Lactococcus lactis or Streptococcus gordonii that express conserved regions of HA or M2 antigens from avian influenza virus (AIV) A. All three vaccines evoked antigen-specific serum immunoglobulin G (IgG) responses in vaccinated chickens. The addition of the adjuvant cholera toxin B (CTB) increased the antigen specific IgG response. Fecal IgA and cell mediated immune responses were not detectable in the chickens. LL-M2e provided significant protection against lethal challenge compared to mock-vaccinated chickens. None of the chickens vaccinated with the control strain (LL-PIP) or mock-vaccine survived lethal challenge past 5 days, whereas 2 of the 12 chickens vaccinated with LL-M2e survived at least 7 days post-infection. An M2e-specific serum IgG concentration of 1100 ng/ml was found to be the minimum required for increased protection against AIV infection. SG-HAe, but not LL-HAe, provided a significant increase in the number of chickens that survived lethal challenge compared to control-vaccinated birds. However, no correlation between HAe-specific serum IgG and survival was found.
License
Resource Type
Fecha Disponible
Fecha de Emisión
Degree Level
Degree Name
Degree Field
Degree Grantor
Commencement Year
Advisor
Committee Member
Academic Affiliation
Non-Academic Affiliation
Subject
Declaración de derechos
Publisher
Peer Reviewed
Language
Replaces

Relaciones

Parents:

This work has no parents.

En Collection:

Elementos